Evaluation of Sputum-Culture Results for Tuberculosis Patients in the United States-Affiliated Pacific Islands
Authors:
- 7 December 2021
- journal article
- research article
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 34 (2-3) , 258-261
Abstract
Sputum-culture confirmation guides tuberculosis (TB) diagnosis and patient management but has previously been reported to be low in the US-Affiliated Pacific Islands (USAPI). We evaluated factors associated with positive sputum-culture results by analyzing TB case surveillance and laboratory data, including sputa quality and quantity for diagnostic specimens from the USAPI. A lower proportion of sputum specimens were reported as culture positive from the USAPI (42%), compared with Hawaii (58%) and the United States (55%). Few (3%) sputa collected from TB patients in the USAPI had both optimal quality and quantity; 40% had optimal quality (mucoid), and 7% had optimal quantity (>5 mL). Suboptimal sputum specimen quality and quantity contributed to fewer sputum-culture positive results in the USAPI. Improving sputum collection and handling might lead to more culture positive results and ultimately improve patient care and TB control in USAPI.Keywords
This publication has 6 references indexed in Scilit:
- Comparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysisThe Lancet Global Health, 2017
- Extrapulmonary tuberculosis in colombian children: Epidemiological and clinical data in a reference hospitalInternational Journal of Mycobacteriology, 2017
- Insights in Public Health: Leveraging Pacific Laboratories to Boost Global Health Security.2016
- New Diagnostics for Childhood TuberculosisInfectious Disease Clinics of North America, 2015
- Molecular Epidemiology of Mycobacterium tuberculosis in the United States–Affiliated Pacific IslandsAsia Pacific Journal of Public Health, 2012
- Diagnostic Standards and Classification of Tuberculosis in Adults and Children: This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999American Journal of Respiratory and Critical Care Medicine, 2000